With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma||University of California San Francisco / Zhenyi An, PhD||Young Investigator Grants||2015||California|
|Understanding the Role of Translational Control in Humanized Mouse Models for Medulloblastoma||University of California San Francisco / Ozlem Aksoy, PhD||Young Investigator Grants||2015||California|
|Zebrafish Modeling of PAX3-FOXO1 Driven Rhabdomyosarcoma||University of Texas Southwestern Medical Center / Genevieve Kendall, PhD||Young Investigator Grants||2015||Texas|
|Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma||Children's Hospital Los Angeles / Shahab Asgharzadeh, MD||Innovation Grants||2015||California|
|Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma||University of Virginia, School of Medicine / John Bushweller, PhD||Innovation Grants||2015||Virginia|
|Characterizing Resistance Mechanisms to BET-Bromodomain Inhibition in MYC-amplified||Broad Institute / Rameen Beroukhim, MD,PhD||Innovation Grants||2015||Massachusetts|
|Synergistic Differentiation Therapy in Neuroblastoma||Duke University / Gerard Blobe, M.D./Ph.D||Innovation Grants||2015||North Carolina|
|Transcriptional Effectors of Activated RAS Signaling in Juvenile Myelomonocytic Leukemia||Boston Children's Hospital / Alan Cantor, MD, PhD||Innovation Grants||2015||Massachusetts|
|Single Cell Analysis of Leukemia Initiation||Stanford University / Michael Cleary, MD||Innovation Grants||2015||California|
|Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma||Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP)||Innovation Grants||2015||Virginia|